Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 2013

View Archived Issues

Development of small-molecule inhibitors of cancer-related transcription factors

Peptide-based anticancer vaccine J-65 induces tumor cell lysis

AstraZeneca presents novel dual inhibitor with activity against crizotinib-resistant cell lines

Researchers detail activity of Notch signaling inhibitor BMS-906024

Boston Therapeutics requests IND meeting for drug designed to reduce postprandial glucose

Preclinical data reported for a novel HIV integrase inhibitor

Galleon Pharmaceuticals demonstrates proof of concept for GAL-021

CvergenX and NCI to develop test to predict radiation therapy success

OTraces reports encouraging results from phase II testing of blood test for breast cancer

Novartis presents first data for mutant BRAF inhibitor LGX-818

Researchers present new data for MGL-3196

Wockhardt patents new agents for bacterial infections

Scientists at Novartis present novel c-Met inhibitors

Panacea Biotec discloses novel SGLT2 inhibitors

Scientists at Bayer synthesize novel CDK9/cyclin T1 inhibitors

Lilly presents preliminary results of clinical trial evaluating LY-2606368 monotherapy

AFFiRiS discloses new vaccines for lipoprotein and cardiovascular disorders

Elorac's naloxone lotion granted fast track designation for pruritus in CTCL

BioSante Pharmaceuticals and ANI Pharmaceuticals enter into new merger agreement

Roche and Ascletis collaborate on danoprevir in China

Enrollment completed in SIRFLOX metastatic colorectal cancer trial

Effects of dietary supplement on postprandial blood glucose tested in subjects with type 2 diabetes

Nestle Health Science and Chi-Med obtain regulatory approvals for joint venture

Biodesix and Bruker Daltonics establish new collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...